Selina Gaertner
About Selina Gaertner
Selina Gaertner serves as the Director of EU Medical Affairs, Marketing & Customer Support at HTG Molecular Diagnostics. With a background in medical affairs and business development, she has held various roles in the life sciences sector and has contributed to research in molecular life sciences.
Current Role at HTG Molecular Diagnostics
Selina Gaertner serves as the Director of EU Medical Affairs, Marketing & Customer Support at HTG Molecular Diagnostics. She has held this position since 2021 and has been instrumental in overseeing medical affairs and marketing strategies within the European Union. Her role encompasses customer support initiatives aimed at enhancing client engagement and satisfaction.
Previous Experience at HTG Molecular Diagnostics
Prior to her current role, Selina Gaertner worked at HTG Molecular Diagnostics in various capacities. She served as the Director of EU Medical Affairs & Marketing for three months in 2021. From 2019 to 2021, she was the Medical Affairs Manager for the EMEA region, and from 2016 to 2019, she held the position of District Manager for Central Europe. Her tenure at HTG Molecular Diagnostics spanned over five years.
Professional Background in Life Sciences
Selina Gaertner has a diverse background in the life sciences sector. She worked as a Business Development Consultant at Novoptim from 2014 to 2016. Earlier, she gained research experience as a Research Assistant at the National University of Singapore from 2013 to 2014 and at BioVersys in 2011. These roles contributed to her expertise in medical affairs and research.
Educational Qualifications
Selina Gaertner holds a Master of Science degree in Life Science from the University of Konstanz, where she studied from 2010 to 2013. She also earned a Bachelor of Science degree in Molecular Life Science from Universität zu Lübeck, completing her studies from 2007 to 2010. Her educational background provides a strong foundation for her work in medical affairs and marketing.
Research Contributions and Collaborations
Selina Gaertner has contributed to research in the field of oncology, presenting findings on fusion type biomarkers affecting overall survival in synovial sarcoma patients. She has collaborated with notable institutions, including the Institute of Pathology at University Hospital Essen and the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland. Additionally, she presented on gene expression profiles of challenging FFPE tissue samples collected during autopsy of COVID-19 patients.